Chris Hall
Chief Executive Officer and President
Replay available
Personalis, Inc. (NASDAQ: PSNL) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Chief Executive Officer and President
Chief Financial and Chief Operating Officer
Chief Medical Officer and EVP R&D
Representative, Lake Street Capital
Representative, Craig Howland
Representative, Needham & Company
Representative, BTIG
Representative, Cowwood
Watch the replay and follow the connected company analysis, news, and investor updates for Personalis, Inc..
WEBVTT 00:00:00.436 -- 00:00:05.483 Greetings. Welcome to the PersonAlysis first quarter 2025 earnings conference 00:00:05.483 -- 00:00:09.950 call. At this time, all participants are in a listen-only mode. 00:00:09.950 -- 00:00:13.535 A question and answer session will follow the formal presentation. 00:00:13.535 -- 00:00:18.722 If anyone should require operator assistance during the conference, please press star 00:00:18.722 -- 00:00:23.349 zero on your telephone keypad. Please note this conference is being recorded. 00:00:23.349 -- 00:00:26.673 I would now like to turn the call over to Caroline Corner. 00:00:26.673 -- 00:00:29.134 Please go ahead. 00:00:29.157 -- 00:00:34.329 Thank you, operator. Welcome to PersonAlysis First Quarter 2025 Earnings Call. 00:00:34.329 -- 00:00:38.953 Joining today's call are Chris Hall, Chief Executive Officer and President, Erin Toshibana, 00:00:38.953 -- 00:00:43.177 Chief Financial and Chief Operating Officer, and Rich Chen, Chief Medical Officer and 00:00:43.177 -- 00:00:48.101 EVP R&D. All statements made on this call that do not relate to matters of historical 00:00:48.101 -- 00:00:51.504 fact should be considered forward-looking statements within the meaning of the U.S. 00:00:51.504 -- 00:00:55.608 securities laws. For example, any statements regarding trends and expectations for our 00:00:55.608 -- 00:01:00.629 financial performance this year and longer term, cash runway and liquidity position, 00:01:00.629 -- 00:01:05.796 revenue expectations and timing, reimbursement goals, size and booking of orders, products, 00:01:05.796 -- 00:01:10.744 services, technology, expansion of clinical volume, future publications, the outcome 00:01:10.744 -- 00:01:15.170 and timing of reimbursement decisions, expectations for existing and fut...